NantHealth, Inc.
NHIQ
$0.05
$0.0494,900.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -9.74% | -39.75% | 23.25% | -53.61% | -25.95% |
| Total Depreciation and Amortization | 228.48% | -5.11% | -5.89% | -3.64% | -0.47% |
| Total Amortization of Deferred Charges | 0.97% | -21.80% | -34.77% | -0.15% | 4.20% |
| Total Other Non-Cash Items | 181.65% | 487.81% | -307.00% | 269.23% | 1.57% |
| Change in Net Operating Assets | -132.59% | 328.72% | 1,084.67% | 1.76% | 82.42% |
| Cash from Operations | -52.35% | 30.37% | 40.52% | -32.84% | 11.86% |
| Capital Expenditure | 100.85% | 51.15% | -4.99% | -139.90% | 24.05% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.85% | 51.15% | -4.99% | -139.90% | 42.72% |
| Total Debt Issued | -100.00% | -- | -- | -- | -28.70% |
| Total Debt Repaid | 100.00% | -- | 28.39% | 94.62% | 32.55% |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 574.46% | -- | 2,817.81% | 202.76% | -26.01% |
| Foreign Exchange rate Adjustments | -218.32% | -1,062.50% | -717.39% | 533.33% | 695.45% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 94.13% | 26.40% | 194.90% | 106.84% | 21.67% |